Leonard Minsky Responds:

Leonard Minsky Responds: Mr. Bernier is concerned about upholding the professional and personal reputation of scholars and scientists, and so am I. This is why NCUPI [the National Coalition for Universities in the Public Interest, of which Mr. Minsky is executive director) has come to the aid of Professor Cantekin in his defense against the University of Pittsburgh Medical School, which has been trying to fire him for blowing the whistle on scientific corruption. At the heart of the UPMS c

Written byLeonard Minsky
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Mr. Bernier is concerned about upholding the professional and personal reputation of scholars and scientists, and so am I. This is why NCUPI [the National Coalition for Universities in the Public Interest, of which Mr. Minsky is executive director) has come to the aid of Professor Cantekin in his defense against the University of Pittsburgh Medical School, which has been trying to fire him for blowing the whistle on scientific corruption.

At the heart of the UPMS campaign against Cantekin is the ludicrous charge that he “stole” data belonging to the principal investigator. Since this research was funded by the public through the N.I.H., how could it be stolen from the P.I.? Who, after all, owns publicly funded research? Bemierhas testified that U. of Pitt. and the P.I. own it. This is a controversial assumption, to say the least, and will soon be the subject of further hearings by the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies